Pancreas 3D Organoids: Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer

被引：71

作者：

Moreira, Leticia ^{[1
,2
,3
]}

Bakir, Basil ^{[1
,2
]}

Chatterji, Priya ^{[1
,2
]}

Dantes, Zahra ^{[4
]}

Reichert, Maximilian ^{[4
]}

Rustgi, Anil K. ^{[1
,2
]}

机构：

[1] Univ Penn, Perelman Sch Med, Dept Med, Div Gastroenterol, Philadelphia, PA 19104 USA

[2] Univ Penn, Perelman Sch Med, Dept Genet, Div Gastroenterol, Philadelphia, PA 19104 USA

[3] Univ Barcelona, IDIBAPS, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Hosp Clin,Dept Gastroenterol, Catalonia, Spain

[4] Tech Univ Munich, Klinikum Rechts Isar, Med Klin & Poliklin 2, Munich, Germany

来源：

CELLULAR AND MOLECULAR GASTROENTEROLOGY AND HEPATOLOGY | 2018年 / 5卷 / 03期

关键词：

3D Organoids; Pancreas; Adenocarcinoma; Personalized Medicine; ESOPHAGEAL EPITHELIAL-CELLS; STEM-CELLS; DUCTAL ADENOCARCINOMA; IN-VITRO; ONCOGENIC KRAS; DRUG RESPONSE; ADULT LIVER; MOUSE; CULTURE; SPHEROIDS;

D O I：

10.1016/j.jcmgh.2017.12.004

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

Pancreatic ductal adenocarcinoma is one of the most aggressive forms of cancer, and the third leading cause of cancer-related mortality in the United States. Although important advances have been made in the last decade, the mortality rate of pancreatic ductal adenocarcinoma has not changed appreciably. This review summarizes a rapidly emerging model of pancreatic cancer research, focusing on 3-dimensional organoids as a powerful tool for several applications, but above all, representing a step toward personalized medicine.

引用

页码：289 / 298

页数：10

共 50 条

[1] PROSTATE CANCER ORGANOIDS: 3D TUMOR MINIATURES AS FRONTLINE MODELS FOR PERSONALIZED MEDICINE
Fernandes, Soraia
Cassani, Marco
Oliver-De la Cruz, Jorge
Durikova, Helena
Filipensky, Petr
Forte, Giancarlo
TISSUE ENGINEERING PART A, 2022, 28 : S438 - S439
[2] Tumor organoids for cancer research and personalized medicine
Hui Yang
Yinuo Wang
Peng Wang
Ning Zhang
Pengyuan Wang
Cancer Biology & Medicine, 2022, 19 (03) : 319 - 332
[3] Tumor organoids for cancer research and personalized medicine
Yang, Hui
Wang, Yinuo
Wang, Peng
Zhang, Ning
Wang, Pengyuan
CANCER BIOLOGY & MEDICINE, 2022, 19 (03) : 319 - 332
[4] Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
Germain, Nicolas
Dhayer, Melanie
Dekiouk, Salim
Marchetti, Philippe
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (07)
[5] Pancreatic Cancer Organoids: An Emerging Platform for Precision Medicine?
Sereti, Evangelia
Papapostolou, Irida
Dimas, Konstantinos
BIOMEDICINES, 2023, 11 (03)
[6] Pancreatic cancer 3D organoids: a co-clinical platform for translational research and ex vivo drug testing
Hussung, S.
Koehler, K.
Koehne, N.
Michalczyk, S.
Mastroianni, J.
Fritsch, K.
Zeiser, R.
Boerries, M.
Wittel, U.
Fritsch, R.
ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 237 - 237
[7] Pancreatic Organoids for Regenerative Medicine and Cancer Research
Casamitjana, Joan
Espinet, Elisa
Rovira, Meritxell
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2022, 10
[8] Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice
Bartucci, Monica
Ferrari, Anna C.
Kim, Isaac Yi
Ploss, Alexander
Yarmush, Martin
Sabaawy, Hatem E.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2016, 4
[9] Pancreatic cancer patient-derived organoids as a tool for personalized medicine
Tiriac, Herve
CANCER RESEARCH, 2020, 80 (16)
[10] Applications of Bioengineered 3D Tissue and Tumor Organoids in Drug Development and Precision Medicine: Current and Future
Devarasetty, Mahesh
Mazzocchi, Andrea R.
Skardal, Aleksander
BIODRUGS, 2018, 32 (01) : 53 - 68

← 1 2 3 4 5 →